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A multi-walled carbon nanotube (MWCNT)-cetyltrimethylammonium bromide (CTAB) surfactant com-
posite modiﬁed glassy carbon electrode (GCE) was developed as a novel system for the determination of
4-aminoantipyrine(AAP). The oxidation process was irreversible over the pH range studied and exhibited
a diffusion controlled behavior. All experimental parameters were optimized. The combination of
MWCNT-CTAB endows the biosensor with large surface area, good biological compatibility, electricity
and stability, high selectivity and sensitivity. MWCNT-CTAB/GCE electrode gave a linear response for AAP
from 5.0109 to 4.0108 M with a detection limit of 1.631010 M. The modiﬁed electrode showed
good selectivity against interfering species and also exhibited good reproducibility. The present elec-
trochemical sensor based on the MWCNT-CTAB/GCE electrode was applied to the determination of AAP
in real samples.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Electrochemistry has many advantages, making it an appealing
choice for pharmaceutical analysis [1,2]. Electrochemistry has al-
ways provided analytical techniques characterized by instru-
mental simplicity, moderate cost, and portability. These techniques
have introduced the most promising methods for speciﬁc appli-
cations [3,4]. Due to similarity in the electrochemical and biolo-
gical reactions, it can be assumed that the oxidation/reduction
mechanisms taking place at the electrode and in the body share
similar principles. Biologically important molecules can be in-
vestigated electroanalytically by voltammetry in order to de-
termine the molecule in different ways. Additional applications of
electrochemistry include the determination of electrode mechan-
isms. The redox properties of drugs can give us insights into their
metabolic fate in in vivo redox processes or pharmacological ac-
tivity [5].
Further, the electroanalytical techniques have been shown to
be excellent for the determination of pharmaceutical compounds
in different matrices. Many of the active constituents of formula-
tions, in contrast to excipients, can be readily oxidized. The se-
lectivity of this method is normally excellent because the analyte
can be readily identiﬁed by its voltammetric peak potential.on and hosting by Elsevier B.V. All
University.
: þ91 836 2747884.
andibewoor).Experimental electrochemical techniques have advantages in
simplicity, cost, and analysis time, compared to other techniques
in the ﬁeld of drug analysis. The use of various electrodes, viz.
mercury [6], solids [7,8], and modiﬁed electrodes [9–18], for
electroanalytical measurements has increased in recent years be-
cause of their applicability to the determination of active com-
pounds that undergo oxidation reactions, which is a matter of
great importance in the ﬁeld of clinical and pharmaceutical
analysis.
4-Aminoantipyrine (AAP, as shown in Fig. 1) is an aromatic
substance with analgesic, antipyretic and anti-inﬂammatory
properties [18]. However, AAP usually produces side effects such
as the risk of agranulocytosis [19]. Although AAP is scarcely ever
administered as an analgesic because of side effects, as a raw
material, it is mostly used to produce 4-aminoantipyrine deriva-
tives, which have better biological activities [20,21]. In addition, it
is used as a reagent for biochemical reactions producing peroxides
or phenols [22,23] and can also be used to detect phenols in the
environment [24]. Since it is widely used in the pharmaceutical
industry, biochemical research and environmental monitoring,
AAP has become an environmental pollutant.
The toxic effect of AAP on experimental animals was reported
[25]. AAP can reduce blood ﬂow [26] and 13,14-dihydro-15-keto
prostaglandin F2 alpha concentration [27] after it is infused into
the blood. AAP can form stable complexes with heme [28].
Different methods have been reported for the determination of
AAP including liquid and gas chromatography, spectrophotometricrights reserved. This is an open access article under the CC BY-NC-ND license
Fig. 1. Chemical structure of 4-aminoantipyrine.
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capillary electrophoresis [33], solid phase spectrophotommetry
[34], different HPLC methods [35–37] and voltammetric method
by using graphite pencil electrode [38]. The main problems en-
countered in using some methods are time-consuming extraction
and separation procedures.
Carbon nanotubes have several applications in the ﬁeld of
semiconductor devices, high performance nano-composites, en-
ergy conversion devices, sensors, etc. [39,40] because of their
nano-scale structure, large surface area, high mechanical strength
and extraordinary electronic properties. There are so many results
on the modiﬁcation of the electrode surface using carbon nano-
tubes [41–44].
In this paper, we demonstrated a successful way to disperse
multiwalled carbon nanotube (MWCNT) within cetyl-
trimethylammonium bromide (CTAB) surfactant. In this procedure,
the surfactant is adsorbed on the surface of MWCNTs, and sub-
sequent ultrasonication of the solution, which takes several min-
utes, will cleave apart their aggregations and debundle nanotubes
by steric or electrostatic repulsions resulted from the charge of
surfactant hydrophilic groups [45–47]. The resulted electro-
chemical sensors exhibited high sensitivity, rapid response, goodFig. 2. Schematic diagram of thereproducibility, low detection limit, renewal of the surface and
freedom from other potentially interfering species.2. Materials and methods
2.1. Apparatus
Electrochemical studies were carried out by CH Instruments
(Electrochemical Analyzer, Model 630D, USA), a three electrode
system consisting of a glassy carbon electrode (GCE) modiﬁed with
MWCN/CTAB as a working electrode, saturated Ag/AgCl/KCl as a
reference electrode and a platinum wire as the counter electrode.
Electrode surface morphology study was carried out by SEM in-
strument model OXFORD instrument INCA PENTA FETX3 CARL
ZEISS (Japan) and Nanosurf Easyscan 2 atomic force microscopy
(AFM) (Switzerland). An Elico LI-120pH meter (Elico Ltd. Hyder-
abad, India) was used to determine the pH of the buffer solution.
2.2. Reagents and chemicals
4-Aminoantipyrine and MWCNT powders were purchased
from Sigma-Aldrich (Mumbai, India). Cetyltrimethylammonium
bromide was from Merck (Bengaluru, India). Double distilled wa-
ter was used throughout the work. All other solvents and materials
used throughout this study were of analytical grade.
2.3. Preparation of modiﬁed electrode
To get reproducible results, great care was taken in the elec-
trode pre-treatment. The GCE was pre-treated in two ways:proposed modiﬁcation steps.
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0.05 mm alumina slurry and (ii) electrochemical treatment by ap-
plying a potential of 1.25 V for 10 s vs. Ag/AgCl. The electro-
chemical pre-treatment was done in the same supporting elec-
trolyte solution in which the measurement was carried out. After
that 10 mL of solution containing 0.3 g/L MWCNTs and 0.2 g/L
CTAB, which was sonicated for 60 min, was placed on the GCE
surface and then evaporated in an oven at 50 °C. The ultra-
sonication of MWCNTs via CTAB will lead to the dispersion of
nanotubes, and ﬁx the surfactants on the surface of MWCNTs
(possible arrangements of CTAB on MWCNTs are illustrated in
Fig. 2 [48]). It can be described that the cationic surfactant will
make the nanotubes positively charged, and these charged
MWCNTs are driven toward cathode to form a thin layer at the
electrode surface.
Eventually, the coated electrodes (MWCNTs-CTAB/GCE) were
immersed in the bicarbonate solution (0.01 M) for 30 min in order
to extract the residual surfactants from the surface of electrode.
The modiﬁed electrodes were washed with distilled water and
dried at room temperature (MWCNTs–GCE). Fig. 3 shows surface
morphology of photography of SEM images of unmodiﬁed and
modiﬁed GCE, and AFM image of modiﬁer.
The area of the electrode was calculated by the cyclic voltam-
metric method using 1.0 mM K3Fe(CN)6 in 0.1 M KCl by recording
the current voltage curve at different scan rates (SupplementaryFig. 3. SEM images of bare glassy carbon electrode and MWCN-CTAB modiﬁed glassy car
GCE, (C) AFM topography of MWCNTs, and (D) AFM topography of MWCNT-CTAB sampFig. 1). For a reversible process, the following Randles–Sevcik for-
mula can be used [49].
I F n A D C v0.4463 /RTp o
3 1/2 3/2
0
1/2
0
1/2)= (
where Ip refers to the cathodic peak current, n is the number of
electrons transferred, A0 is the surface area of the electrode, D0 is
diffusion coefﬁcient, v is the scan rate and C0 is the concentration
of K3Fe(CN)6. For 1.0 mM K3Fe(CN)6 in 0.1 M KCl electrolyte, n¼1,
DR¼7.6106 cm2/s, then from the slope of the plot of Ip versus
v1/2, the electro active area was calculated. In our experiment, the
slope was 0.695 and the area of electrode was calculated to be
0.117 cm2. The area of the unmodiﬁed glassy carbon electrode was
calculated to be 0.0448 cm2.
2.4. Plasma sample preparation
Human plasma sample was prepared as described in the earlier
report of our work [50]. Human blood samples were collected in
dry and evacuated tubes (which contained saline and sodium ci-
trate solution) from a healthy volunteer. The samples were han-
dled at room temperature and centrifuged for 10 min at 1500 rpm
for the separation of plasma within 1 h of collection. The samples
were then transferred to polypropylene tubes and stored at
20 °C until analysis. The plasma samples, 0.2 mL, were depro-
tonised with 2 mL of methanol. After vortexing for 15 min, thebon electrode. (A) SEM image of bare GCE, (B) SEM image of MWCNT-CTAB modiﬁed
le.
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pernatants were collected.
2.5. Pharmacokinetic study
Serum samples of a healthy volunteer were collected as de-
scribed in Section 2.4 and stored at 20 °C until analysis. Into each
of 10 centrifugation tubes (3 mL polypropylene microcentrifuge
tubes) containing 1.0108 M concentration of AAP, 100 μL vo-
lume of the human serum was transferred, then mixed well with
1 mL of methanol to denature and precipitate proteins. The solu-
tions were centrifuged for 3 min at 14,000 rpm to separate out the
precipitated proteins. The clear supernatant layers of these solu-
tions were ﬁltered through 0.45 μm millipore ﬁlters to produce
protein-free human serum samples. Each sample was analyzed at
different time intervals by using differential pulse voltammetry.Fig. 5. Inﬂuence of pH on the electro-oxidation of 0.1 mM of AAP. (a)–(e): 3.0, 4.2,
5.0, 6.2, 7.0.3. Results and discussion
3.1. Cyclic voltammetric study of 4-aminoantipyrine
The electrochemical response of 0.1 mM AAP was investigated
by cycle voltammetry between 0.2 and 0.8 V in phosphate buffer
solution of pH 3.0 at GCE, MWCNT/GCE and MWCNT-CTAB/GCE
(Fig. 4). At GCE, a poorly deﬁned oxidation peak was observed and
the peak current was smaller. AAP exhibited well deﬁned anodic
peak at 0.512 V at MWCNT/GCE. The oxidation peak current in-
creased greatly at MWCNT-CTAB/GCE (the voltammogram as
shown in Fig. 4). It indicates that MWCNT-CTAB/GCE can make the
electron transfer of AAP easily. No reduction peak was observed in
the reverse scan, suggesting that the electrochemical reaction was
totally irreversible process.
3.2. Effect of amount of MWCNT-CTAB suspension
We examined the effect of MWCNT-CTAB suspension amount
on the electrochemical behavior of AAP. The results suggested that
the amount of MWCNT-CTAB suspension inﬂuenced the current
responses of AAP. Supplementary Fig. 2 demonstrates the re-
lationship between the oxidation peak current of AAP and the
amount of MWCNT-CTAB suspension used for coating GC elec-
trode. As can be seen, the peak current gradually increased with
increasing the amount of MWCNT-CTAB suspension from 0 to
10 μL, owing to the increased effective electrode surface area forFig. 4. Typical cyclic voltammograms of 0.1 mM 4-aminoantipyrine at (a) bare GCE,
(b) GCEþMWCNT and (c) GCEþMWCNT-CTAB.AAP oxidation. Further increasing the amount of MWCNT-CTAB
suspension, the peak current almost remained stable. However,
when it exceeded 14 μL, the peak current slightly decreased. When
the coating ﬁlm was too thick, the ﬁlm no longer adhered tightly
to the glass carbon, reducing conductivity and part of the MWCNT-
CTAB left the electrode surface. More excessively coated amount of
MWCNT-CTAB suspension led to less adherent ﬁlm. Accordingly,
10 μL of MWCNT-CTAB suspension solution providing the max-
imum current response was used in further experiments, while
the amount of suspension of MWCNT-CTAB had little effect on the
oxidation potential of AAP.3.3. Effect of pH
The pH of the supporting electrolyte had a noticeable effect on
the electro-oxidation of analyte under investigation. The electro-
oxidation of AAP was carried out by cyclic voltammetry at the
surface of MWCNT-CTAB modiﬁed GCE over the pH range 3.0–7.0.
The peak potential shifted to more negative values with an in-
crease in solution pH (Fig. 5). The sharp and well-deﬁned oxida-
tion peak was observed in phosphate buffer of pH 3. Hence, we
selected phosphate buffer of pH 3 for further studies.3.4. Effect of scan rate
The cyclic voltammograms of 0.1 mM AAP on the MWCNT-
CTAB modiﬁed GCE at different scan rates are shown in Fig. 6A.
The observation was made to investigate the kinetics of the elec-
trode reaction. With the increase of the scan rate, the oxidation
peak current also increased gradually, indicating the direct elec-
tron transfer between AAP and modiﬁed electrode surface. In the
range from 10 to 100 mV/s the oxidation peak current was pro-
portional to the scan rate (Ipa(10 mA)¼0.0430.099 v1/2) and the
correlation coefﬁcient was 0.984, which indicated that the electron
transfer reaction was a diffusion-controlled process [51]. A linear
relationship was observed between log Ipa and log v (log Ipa (μA)¼
0.3088 log v (V/s)þ1.275; r¼0.976). The slope value of 0.3088
conﬁrms that the electro-oxidation of AAP was diffusion
controlled.
A linear relation between peak potential (Epa) and log ν was
obtained, Epa¼0.018 log vþ0.445 (Fig. 6B). Such behavior revealed
the irreversible nature of the electrochemical process for AAP.
According to Laviron, for a diffusion-controlled irreversible process
Fig. 6. (A) Cyclic voltammograms of 0.1 mM AAP at different scan rates (1–10: 10,
20, 30, 40, 50, 60, 70, 80, 90, 100 mV/s) in 0.2 M phosphate buffer (pH 3.0).
(B) Relationship between peak potential and logarithm of scan rate.
Fig. 7. Differential pulse voltammograms of AAP at different concentrations at
MWCNT-CTAB/GCE: (1)–(14) 0.5108–4.0108 M. Inset: plot of the con-
centration vs. peak current of AAP at MWCNT-CTAB/GCE.
J.I. Gowda et al. / Journal of Pharmaceutical Analysis 5 (2015) 231–238 235[52], Epa is deﬁned by the following equation:
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟
⎛
⎝⎜
⎞
⎠⎟E E nF
k
nF nF
2.303RT
log
RT 2.303RT
logpa
0
0
α α α
ν= + +
where α is the transfer coefﬁcient, k0 is the heterogeneous electron
transfer rate constant of the reaction, n is the number of trans-
ferred electrons, v is the potential scan rate and E0 is the formal
redox potential. The other symbols have their usual meaning. This
relationship allows n to be readily calculated from the slope of the
Epa vs. log v plot. Taking T¼298 K, R¼8.314 J/K mol and
F¼96480 C and the value α was calculated from Bard and Fualkner
equation, which is equal to 1.325, the value of n was calculated to
be 2.47E2 for AAP.
If E0 is known, the value of k0 can be estimated from the in-
tercept of the above plot. E0 in the above equation can be obtained
from the ordinate intercept of the Epa vs. v curve at v¼0 [53]. The
obtained k0 was 9.845103/s.
3.5. Calibration curve
In order to develop the voltammetric method for determina-
tion of the drug, we chose the differential pulse voltammetric
method for the reason that the peaks were sharper and more
distinct at a lower concentration of AAP than those obtained by
CV, with a lower background current, resulting in enhanced re-
solution. In keeping with the obtained results, it was feasible to
apply this technique to the quantitative analysis of AAP. The
phosphate buffer solution of pH 3.0 was selected as the supportingelectrolyte for the quantiﬁcation as AAP gave maximum peak
current. Differential pulse voltammograms obtained with in-
creasing amounts of AAP showed that the peak current increased
linearly with increased concentration. Linear calibration curves
were obtained for AAP concentration in the range of 5.0109–
4.0108 M (Fig. 7). Linear equation was Ipa¼4.47(108 M)–0.606
(r¼0.988). Interrelated statistical data of the calibration curves
were procured from the three different calibration curves. Limits
of detection (LOD) and quantiﬁcation (LOQ) were calculated based
on the peak current using the following equations:
s m s mLOD 3 / ; LOQ 10 /= =
where s is the standard deviation of the peak currents of the blank
(three replicates), and m is the slope of the calibration curve. The
LOD and LOQ values were 1.631010 M, and 5.421010 M,
respectively. The detection limits reported at different analytical
methods for AAP related dipyrone derivative drugs are tabulated
in Table 1. The proposed method was better than other reported
electrochemical methods [31,38,54–56].
3.6. Robustness and effect of excipients
The robustness of the method was checked by evaluating the
inﬂuence of small variations of some of the most important vari-
ables, including pH, accumulation time and potential range. The
results indicated that none of these variables signiﬁcantly affected
the recovery of AAP. This provided an indication of the depend-
ability of the proposed process for the assay of AAP, and the pro-
posed method could be measured robustly.
For the possible analytical application of the proposed method,
the effect of some common excipients used in pharmaceutical
preparations was examined. The tolerance limit was deﬁned as the
maximum concentration of the interfering substance that caused
an error less than 5% for determination of AAP. The experimental
results showed that hundred-fold excess of citric acid, dextrose,
glucose, gum acacia, lactose, tartaric acid and sucrose did not in-
terfere with the voltammetric signal of AAP. This showed that the
electrode was much selective towards AAP.
3.7. Reproducibility of the modiﬁed electrode
The renewal and reproducibility of the electrode were in-
vestigated. It was found that after determination the surface of the
MWCNT-CTAB/GCE could be regenerated by successively cycling
between 0 and 1.2 V in 3.0 pH with 0.2 M phosphate buffer after
Table 1
Comparison of detection limits for AAP related dipyrone derivative drugs by different methods.
Dipyrones Methods LOD Ref.
1)Dipyrone(DP)(1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylaminomethane-
sulfonate sodium)
1. Flow injection amperometric determination 2.78104 M [31]
2. Diffusion layer titration at dual-band electro-
chemical cell
3.6 μM [54]
3. Nano-Riboﬂavin-modiﬁed glassy carbon elec-
trode(voltammetry)
0.0502 μM [55]
4. Titanium phosphate/nickel
hexacyanoferrate mod graphite electrode
(voltammetry)
3.75104 M [56]
2) 4-Aminophenazone Graphite pencil electrode(voltammetry) 0.45107 M [38]
3) 4-Aminoantipyrine MWCNT-CTAB modiﬁed glassy carbon electrode 1.631010 M Present work
J.I. Gowda et al. / Journal of Pharmaceutical Analysis 5 (2015) 231–238236washing the electrode with water and acetone. As an example,
0.1 mM AAP solution was measured successively for 5 times with
the same electrode regenerated through such procedure after ev-
ery determination, the relative standard deviation (RSD) of the
peak current was 1.15%. As to the reproducibility between some
days, it was similar to that of within a day, if the temperature was
kept almost unchanged. Peak current obtained for 0.1 mM AAP
solution on different days is shown in Supplementary Fig. 3. Ow-
ing to the adsorption of AAP or its reductive products on to the
electrode surface, the current response of the modiﬁed electrode
would decrease after successive use. In this case, the electrode
should be prepared again.
3.8. Determination of AAP in biological samples
The applicability of the proposed method for the determination
of AAP in biological ﬂuid of human urine and plasma samples was
attempted. Drug-free human urine and plasma samples, obtained
from healthy volunteers, were ﬁltrated through a ﬁlter paper and
stored frozen until the assay. The developed differential pulse
voltammetric method for the AAP determination was applied to
urine and plasma samples. The recoveries from urine and plasma
were measured by spiking drug-free urine and plasma with known
amounts of AAP. The urine and plasma samples were diluted with
the phosphate buffer solution before analysis without further pre-
treatment. A quantitative analysis could be carried out by adding
the standard solution of AAP into the detection system of urine
and plasma samples. The calibration graph was used for the de-
termination of spiked AAP in urine samples. The detection results
of urine and plasma samples are listed in Table 2. The recovery
determined was in the range of 98.02%–103.46% for human plasma
and 99.16%–102.17% for urine sample. Thus, satisfactory recoveriesTable 2
Application of DPV to the determination of AAP in spiked human urine and blood
plasma samples.
Sample Added
(108 M)
Founda
(108 M)
Recovery (%) RSD (%) Bias (%)
Human
plasma
1 0.3 0.303 101.00 0.7817 1.00
2 0.7 0.696 99.42 0.2962 0.57
3 3.0 3.104 103.46 1.5017 3.46
4 7.0 6.862 98.02 0.1676 1.97
Human
urine
1 0.2 0.198 99.40 0.8645 0.60
2 0.5 0.495 99.16 0.7158 0.84
3 6.0 6.130 102.17 0.3805 2.17
4 8.0 7.979 99.74 0.2937 0.25
a Average of ﬁve determinations.of the analytes from the real samples and a good agreement be-
tween the concentration ranges studied and the real ranges en-
countered in the urine and plasma samples when treated with the
drug made the developed method applicable in clinical analysis.3.9. Application to pharmacokinetic studies
Pharmacokinetics is the study of the time course of drug ab-
sorption, distribution, metabolism, and excretion. Clinical phar-
macokinetics is the application of pharmacokinetic principles to
the safe and effective therapeutic management of drugs in an in-
dividual patient. Primary goals of clinical pharmacokinetics in-
clude enhancing efﬁcacy and decreasing toxicity of a patient's drug
therapy. The development of strong correlations between drug
concentrations and their pharmacologic responses has enabled
clinicians to apply pharmacokinetic principles to actual patient
situations. A drug's effect is often related to its concentration at
the site of action, so it would be useful to monitor this con-
centration. Receptor sites of drugs are generally inaccessible to our
observations or are widely distributed in the body, and therefore
direct measurement of drug concentrations at these sites is not
practicable. However, drug concentration in the blood or plasma,
urine, saliva and other easily sampled ﬂuids can be measured.
The assay results are shown in Supplementary Fig. 4, which
illustrates the proﬁle of the plasma concentration vs. time for AAP.
The results suggested that the disposition of AAP was conformable
to a one compartment open model. Table 3 shows the peak re-
sponse of drug concentration at different time intervals and some
the pharmacokinetic parameters for AAP in the plasma sample.Table 3
Response of peak current of 1108 M AAP in urine sample at different time
intervals.
Time (min) Peak current
(104 A)
Concentration (108 M)
0 3.402 1.000
10 3.392 0.997
20 3.254 0.956
30 2.954 0.868
40 2.358 0.693
50 1.995 1.754
60 1.754 0.515
70 1.588 0.466
80 1.208 0.355
90 0.950 0.279
100 0.554 0.162
Elimination rate constant
(h-1)
0.167
Half life of drug (h) 4.14
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The voltammetric behavior and oxidation mechanism of AAP
were investigated at an MWCN-CTAB/GCE by CV in phosphate
buffer solution of pH 3.0. Based on this study, inﬂuences of several
physicochemical parameters such as potential scan rate, pH and
concentration were investigated. The oxidation of AAP was found
to be an irreversible with diffusion character. MWCNT-CTAB/GCE
showed electrocatalytic action for the oxidation of AAP, char-
acterizing by the enhancement of the peak current, which was
probably due to the larger effective surface area of MWCNT-CTAB.
This method was successfully used to determine AAP in the hu-
man urine and plasma samples. The proposed method offered the
advantages of accuracy and time saving as well as simplicity of
reagents and apparatus. In addition, the results obtained in the
analysis of AAP in spiked urine and plasma samples demonstrated
the applicability of the method for real sample analysis.Acknowledgments
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